Propensity score-based analysis of 30-day survival in cardiogenic shock patients supported with different microaxial left ventricular assist devices.
Gaik NersesianEvgenij V PotapovVivian NelkiJulia SteinChristoph StarckVolkmar FalkFelix SchoenrathFlorian KrackhardtCarsten TschöpeFrank SpillmannPublished in: Journal of cardiac surgery (2021)
Both Impella devices offer a similar effect with regard to survival in cardiogenic shock patients. Preoperative CPR or lactate levels exceeding 8 mmol/L immediately before implantation have a poor prognosis on Impella CP and Impella 5.0/5.5.
Keyphrases